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Abstract
Early vascularization is a prerequisite for successful bone healing and endothelial progenitor cells (EPC), seeded on
appropriate biomaterials, can improve vascularization. The type of biomaterial influences EPC function with bioglass
evoking a vascularizing response. In this study the influence of a composite biomaterial based on polylactic acid (PLA) and
either 20 or 40% bioglass, BG20 and BG40, respectively, on the differentiation and survival of EPCs in vitro was investigated.
Subsequently, the effect of the composite material on early vascularization in a rat calvarial critical size defect model with or
without EPCs was evaluated. Human EPCs were cultured with b-TCP, PLA, BG20 or BG40, and seeding efficacy, cell viability,
cell morphology and apoptosis were analysed in vitro. BG40 released the most calcium, and improved endothelial
differentiation and vitality best. This effect was mimicked by adding an equivalent amount of calcium to the medium and
was diminished in the presence of the calcium chelator, EGTA. To analyze the effect of BG40 and EPCs in vivo, a 6-mm
diameter critical size calvarial defect was created in rats (n=12). Controls (n=6) received BG40 and the treatment group
(n=6) received BG40 seeded with 5610
5 rat EPCs. Vascularization after 1 week was significantly improved when EPCs were
seeded onto BG40, compared to implanting BG40 alone. This indicates that Ca
2+ release improves EPC differentiation and is
useful for enhanced early vascularization in critical size bone defects.
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Introduction
Biomaterial-based strategies in bone tissue engineering combine
principles of biology and engineering to develop functional
substitutes for damaged bone and improve bone regeneration.
Designing and fabricating composite biomaterials for bone
regeneration from different synthetic biodegradable polymers
and bioactive materials is an essential step in engineering bone
tissue [1–5].
Biomaterials serve as matrices for tissue formation and surface
properties promoting cell adhesion, proliferation and differentia-
tion, desirable mechanical properties, non-cytotoxicity and
osteoconductivity are all essential [6,7]. Bioglass (BG), a calcium
silicate (CaO-SiO2), is similar to the natural inorganic bone
component and has been shown to stimulate the formation,
precipitation and deposition of calcium phosphates from physio-
logical solution and can result in enhanced bone-matrix interface
strength [8].
Recently, composite biomaterials comprising a bioactive
bioglass and a biodegradable polymeric component have been
developed for bone tissue engineering scaffolds [9,10]. The
composite materials were designed to mimic bone-forming
components, to elicit specific cellular responses due to the release
of highly reactive components and provide an ideal environment
for bone formation [11,12].
Reparative cells are also an important aspect of bone tissue
engineering and they require a biomaterial scaffold, which
positively influences cell adhesion, morphology, proliferation and
differentiation of neighbouring cells [13,14]. Relatively little is
known about the effect of composite materials containing a
bioglass fraction on cells with regenerative capabilities. Previous
studies have predominantly focussed on marrow stromal cells
(MSC). It has been demonstrated that bioglass materials are well
tolerated by MSC, improving their function and differentiation,
probably due to calcium ion release [15,16].
However, depending on the size of the bone defect, the survival
and growth of MSC seeded onto a biomaterial influence the in-
growth of endogenous bone-forming cells and may be limited due
to lacking vascularization and insufficient nutritional bone graft
support. Thus, early vascularization of the composite material in
the bone defect is a crucial step for in-growth of osteogenic
reparative cells in regenerating bone in vivo [17]. Improvement of
early vascularization has been achieved through the use of
endothelial progenitor cells (EPC) [18,19], isolated from diverse
starting populations [20].
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EPCs’’ were used. These cells are presumably derived from
monocytic/dendritic cells coexpressing some endothelial markers
together with leukocyte markers and demonstrating a high VEGF
synthesis [21–24]. In the following ‘early EPCs’ will be referred to
as EPCs.
Early EPCs are presumably derived from monocytic/dendritic
precursors, express the common leukocyte marker CD45 and
some investigators therefore designate them as endothelial like
differentiated PBMCs. These cells can be generated in a sufficient
amount within 3 to 5 days from a reasonable volume of blood.
Early EPCs are potent producers of vascular endothelial growth
factor (VEGF) [21–24].
Outgrowth EPCs or late EPCs are characterized by a broad
spectrum of endothelial markers including VEGF-R2 and UEA-I-
Lectin. They express CD34, lack myeloid markers (CD45) and can
be expanded in vitro. It is likely that these cells are generated from
bone-marrow derived CD133+ cells [25,26]. The culture period of
late EPCs is much longer, compared to that of early EPCs. Single
colonies of late EPCs appear after 3–4 weeks [27], whereas early
EPCs require only 3–5 days [28,29].
There is wide spread evidence that EPCs can be cultured to be
functionally active on ceramic and natural biomaterials, alone and
in combination with marrow stromal cells (MSC) [19,30,31]. It has
also been demonstrated that EPCs seeded on ceramic biomaterials
are capable of increasing the vascularization in bone defects within
one week after implantation [19,32,33].
Recently, the combination of ‘‘bone marrow-derived EPCs’’
which require a culture period of at least 12 days, with polylactic
acid (PLA) and a bioglass was analyzed in vitro [34]. This
composite material promoted EPC mobilisation, differentiation
and angiogenesis, likewise probably due to ionic calcium and
mechanical cues [34]. No data is available about the effect of PLA-
bioglass biomaterial combined with ‘‘early EPCs’’ on early
vascularization in a critical size bone defect in vivo.
Therefore, the current investigation was designed to elucidate
the effect of a composite material consisting of polylactic acid and
increasing fractions of bioglass on early EPCs in vitro. The amount
of calcium released from the composite material was measured
and morphological changes and apoptosis of EPCs in vitro were
recorded. Subsequently, EPCs were incubated with equivalent
calcium concentrations and morphological changes, vitality and
apoptosis of the EPCs were recorded. The effect of the composite
material combined with EPCs on early vascularization (after 1




Human early EPCs were isolated from buffy coat (Red Cross
Blood Donor Service, Frankfurt, Germany). The use of anony-
mous buffy coat for research purposes was approved by the local
ethics committee (Ethik-Kommission des Fachbereichs Medizin
der Johann Wolfgang Goethe-Universita ¨t, Project No. 329/10)
and the donors signed informed consent.
All animal experiments were approved and performed in
accordance with regulations set forth by our institution’s animal
care and oversight committee located at the Regierungspra ¨sidium
Darmstadt (Regierungspra ¨sidium Darmstadt – Veterina ¨rdezernat
- Tierschutzkommission, Darmstadt, Germany, Project No. F3/
22), in accordance with German law. All surgery was performed
under general anesthesia, which was administered intraperitone-
ally as a mixture of Ketavet and Rompun. All efforts were made to
minimize suffering. The animals were sacrificed with an overdose
of pentobarbital (150 mg/kg i.p.).
Biomaterial Characterisation: PLA, BG20, BG40 and b-TCP
The composite biomaterials consisted of a PLA-component
supplemented with either 20 or 40% bioglass (BG). Tetraethyl
orthosilicate (TEOS, $99%) and nitric acid 65% were supplied by
Merck Chemicals KgaA (Darmstadt, Germany). Calcium nitrate
[Ca (NO3)2 4H2O, $99%], poly (L-lactide) and chloroform
(CHCl3, $99.4%) were purchased from Sigma-Aldrich (Stein-
heim, Germany). All chemicals were reagent grade and used
without further purification. For bioglass synthesis (CaO-SiO2 -
SiO2 80 mol-%, CaO 20 mol-%), a low viscosity gel was obtained
by mixing 31 mL of tetraethyl orthosilicate (TEOS) and 8.6 g of
Ca(NO3)2.4H2O in a solution of 5.5 mL of HNO3 2 M, used as
catalyst, in 31.5 mL H2O. The initial pH was 0.5. The bioglass
was cast at room temperature in a Teflon container (Thermo
Scientific Nalgene, Germany) until the gel had hardened. Aging
was performed at 60uC for 3 days. Drying was carried out at
120uC. The glass was collected in a porcelain crucible (Halden-
wanger GmbH, Waldkraiburg, Germany) and heated in a muffle
furnace (Nabertherm GmbH, Lilienthal, Germany) at a rate of
3uC/1 minute to 700 Cu and maintained at 700uC for 3 hours.
The glass particles were ground to powder in a small porcelain
mortar (Haldenwanger GmbH, Waldkraiburg, Germany). The
particles were then sieved to achieve a size ranging from 106 mm
to 125 mm by sieves with a mesh size of 106 mm and 125 mm
(Retsch GmbH, Haan, Germany). Composite biomaterials were
prepared by mixing polymer [poly(L-lactide)(PLA)] and bioglass
with 10 ml chloroform as follows: PLA, PLA/BG 20% and PLA/
BG 40% biomaterial. The bioglass content was 0%, 20% and 40%
by weight. These biomaterials will be referred to as PLA, BG20
and BG40, respectively. Disc shaped specimens with a diameter of
5 mm and a thickness of 1 mm were cut and stored at room
temperature under sterile conditions until use (Fig. 1A). The
synthetic b-tricalcium phosphate (b-TCP) ChronosH (Synthes,
Du ¨bendorf, Switzerland) was employed as a reference material
[19,31,32,33]. The b-TCP particles have a size of 0.7–1.4 mm,
porosity 60%, pore size 100–500 mm, low mechanical stability
and moderate biodegradability.
Scanning Electron Microscopy
Surface topography, roughness and morphology of the bioma-
terial, as well as adherent EPCs, were assessed by scanning
electron microscopy (SEM). Untreated biomaterials and biomate-
rials seeded with EPCs were fixed 5 days after EPC seeding with
glutaraldehyde for 30 min and subsequently dehydrated by
15 min incubation in a 5-step ethanol gradient (25%, 50%,
75%, 96%, 100% ethanol). Biomaterials were then incubated
overnight in 1,1,1,3,3,3-hexamethyldisilazane (Merck-Schuchardt,
Hohenbrunn, Germany) and drained. Afterwards the samples
were sputtered with gold (3660 s, Agar Sputter Coater, Agar
Scientific Ltd., UK) using a Hitachi FE-SEM S4500 (Hitachi,
Dusseldorf, Germany) with a voltage of 5 kV. The images were
digitally recorded using the Digital Image Processing System 2.6
(Point Electronic, Halle, Germany). The public domain software
ImageJ (http://rsb.info.nih.gov/ij/) was used to evaluate pore size,
pore density and fiber diameter.
Calcium Release
30 mg of cell free BG20, BG40, control PLA or b-TCP were
placed in individual wells of 24 well plates and incubated over a
period of 2, 6 or 10 days with 1 mL endothelial basal medium
(EBM, Cambrex, Verviers, Belgium) supplemented with endothe-
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At the indicated time points Ca
2+ in the medium was measured
(ABL 800 Flex; Radiometer GmbH, Willich, Germany). The
calcium content of untreated EBM-medium served as control.
Cell Preparation and Culture
Isolation of early EPCs from buffy coat and rat
spleen. Due to accessibility, early human EPCs were employed
for all in vitro experiments. To avoid host versus graft reactions
EPCs isolated from rat spleen were used in the animal study.
Buffy coat was subjected to density gradient centrifugation
(30 min, 900 g) with Ficoll (1.077 g/ml, Biochrom, Berlin,
Germany). Recovered mononucleated cells were washed twice
with cold PBS
w/o (10 min, 900 g) and 2610
6 cells/cm
2 were
cultivated on fibronectin coated (10 mg/ml, Sigma, Deisenhofen,
Germany) culture dishes with endothelial basal medium (EBM,
Cambrex, Verviers, Belgium) supplemented with EGM Single-
Quot at 37uC, 5% CO2. After 48 hours, non- and weakly-
adherent cells were removed, the medium was changed and the
cells were cultivated for an additional 72 hrs. A parallel
preparation was performed to evaluate the percentage of
endothelial differentiated cells. EPCs were identified by staining
with 1,19-dioctadecyl-3,3,39,39-tetramethylindo-carbocyanine-la-
beled acetylated low density lipoprotein (DiLDL, Cell-Systems,
St. Katharinen, Germany) in EBM supplemented with 20% FCS.
Cells were fixed with 2% paraformaldehyde for 10 min and after
washing with PBS
+/+ FITC-labeled Ulex europaeus agglutinin-1
[10 mg/ml] (lectin, Sigma, Deisenhofen, Germany) were incubat-
ed for 1 h. Cells with double-positive fluorescence were considered
to be EPCs [28,29]. Only preparations with a percentage of
endothelial like differentiated cells greater than 80% were used.
For experiments the cells were detached by accutase treatment
(10 min) (PAA-laboratories, Linz, Austria), washed once with
EBM+supplements (Cell-Systems, St. Katharinen, Germany) and
subsequently adjusted to a density of 5610
5 cells in 50 ml. Rat
EPCs were isolated from the spleen of homozygous male SD-rats.
The spleen was cut in small pieces (approximately 3 mm) and
gently mashed using syringe plungers. The cell suspension was
filtered through a 100 mm mesh, washed once with PBS and
layered onto a ficoll density gradient. The subsequent following
isolation, culture and identification were identical to the proce-
dures described for human EPCs.
Figure 1. Surface structure and calcium release of the composite scaffold BG40. Disc shaped polymer/bioglass scaffold BG40, with a
diameter of 5 mm and a thickness of 1 mm (A). A representative SEM image of BG40 is shown in (B). The composite demonstrates a relatively smooth
surface with a thin fibrous texture and small pores (arrows). Scale bar indicates 6 mm. The release of ionic calcium to medium by BG40 (B4), BG20 (B2),
PLA (P) and b-TCP (T) is shown in C. The most ionic calcium was released within the first two days. *=p,0.05 BG20, BG40 vs b-TCP, PLA; $=p,0.05
BG40 vs BG20, n=5.
doi:10.1371/journal.pone.0079058.g001
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Seeding efficacy of early EPCs on composite
biomaterial. Composite biomaterial chips (BG20, BG40) and
PLA chips (Fig. 1a) were individually placed in single wells of a 96-
well plate (Nunc, Wiesbaden, Germany) using sterile forceps.
Granules of b-TCP were placed in a dense monolayer in single
wells of a 96-well plate as additional controls.
5610
4 EPCs in a volume of 50 ml were dripped onto the
biomaterials and incubated for 10 min at 37uC. After incubation
the medium containing non-adherent cells was removed and
dripped once again over the biomaterials, followed by incubation
as indicated above. This procedure was repeated three times. The
bioglass chips or b-TCP granules were then gently transferred to
another well containing 100 ml EBM2+EGM2 Singlequot. The
remaining cells in the supernatant and at the bottom of the initial
seeding well were isolated, counted and the percentage of adherent
cells was calculated ((initial cell number - remaining cell number)/
initial cell number)*100. The experiment was performed in
duplicate and was repeated 5 times.
Effect of Composite Biomaterials on EPC Vitality,
Morphology, Apoptosis and Gene Expression
Twenty-four well plates were coated with fibronectin as
described above. 1610
5 EPCs in 1 mL EBM2+EGM2SQ were
placed in each well. Transwell inserts with a pore size of 8 mm,
containing equal amounts of biomaterials [30 mg of BG20, BG40,
control PLA or b-TCP], were placed in the wells. The pores
allowed diffusion of soluble biomaterial components to the cell
compartment. After 2, 5 and 10 days the morphology of the cells
was assessed by phase contrast microscopy at 100 fold magnifi-
cation. Cells were photographed and the length of the EPCs was
evaluated using the software Axiovison 4.7 (Zeiss). An increase in
cell length is a cellular characteristic of early EPCs [21,35].
The funcionality of the cells was assessed by DiL-ac-LDL
staining on day 5. The amount of DiL-ac-LDL uptake reflects
EPC metabolic status and can be measured by image analysis as
mean pixel brightness/cell [19,30]. DiL-ac-LDL-stained cells were
photographed at 100 fold magnification with equal exposure
(200 mS]. In each group (control, calcium [10 mM], BG40,
BG40+ EGTA [3 mM]) the mean pixel brightness of 20 cells was
analyzed (ImageJ (http://rsbweb.nih.gov/ij/).
Detection of necrotic EPCs on the biomaterials. Necrotic
EPCs were detected by staining nuclei with DAPI (2-(4-
Amidinophenyl)-6-indolecarbamidine, Sigma-Aldrich, Deisenho-
fen, Germany). DAPI passes less efficiently through the membrane
of living cells and thus the staining of living cells is much lower
[36].
Each 5610
4 DiL-ac-LDL prestained EPCs were then seeded
onto chips of PLA, BG20 and BG40 that were placed in individual
wells of 24-well plates. The seeding procedure was performed as
described above. The medium was removed on day 3 and day 5
and a DAPI-solution [final concentration 1 mg/ml in PBS] was
added to each well. The DAPI solution was removed after 3 min
followed by three washings with 1 mL PBS for each wash. The
samples were then subjected to fluorescence microscopy. Five
random high power fields were recorded per scaffold at 100 fold
magnification. Cells with red fluorescence (DiLac-LDL) were
judged as vital cells, cells with red and blue (DAPI) fluorescence
were deemed necrotic. Results are presented as number of
adhering cells per microscopic field of view (FOV) at 100 fold
magnification as well as percentage of necrotic cells per FOV.
To evaluate the effect of Ca
2+-ions on EPC function, CaCl2 was
added to EPC cultured in fibronectin coated 24-well plates in the a
concentration measured in the aforementioned experiments
[10 mM].
Morphological changes and viability of the EPCs were assessed
on day 5 after adding CaCl2, as previously described. Additionally,
EPC apoptosis was assessed on day 3 after CaCl2 addition. The
cells were detached by Accutase treatment and apoptosis was
assessed by means of Annexin-V-staining (Annexin V apoptosis
detection Kit, BD-Biosciences, Heidelberg, Germany) and flow
cytometry (FACScalibur, BD-Biosciences), according to the
manufacturer’s instructions. All experiments described in this
paragraph were performed with 5 different EPC-preparations.
Expression of endothelial marker genes by Real time RT-
PCR. 5610
4 EPCs were seeded onto PLA, BG20 or BG40 chips
and incubated for 3 or 5 subsequent days. EPCs subjected to
RNA-isolation on the day of seeding served as day zero.
Total RNA was isolated using the RNeasy-system (Qiagen,
Hilden, Germany) following the manufacturer’s instructions, with
the following exception. Each chip of biomaterial (PLA, BG20,
BG40) was individually incubated with approximately 100 ml RLT
buffer for 3 min, the mixture was gently vortexed and the
supernatant was subjected to the RNA isolation procedure. The
quality and quantity of RNA was determined using a NanoDrop
ND-1000 device (Nanodrop technologies, Wilmington, Delaware,
USA). Contaminating genomic DNA was removed by digestion
with the RNase free DNase-Kit following the manufacturer’s protocol
(Qiagen).
75 ng of RNA was reverse transcribed using an Affinity script
QPCR-cDNA synthesis kit (Stratagene, La Jolla, CA, USA), following
the manufacturer’s instructions.
Real time RT-PCR was performed on a Stratagene MX3005p
qPCR system (Stratagene, La Jolla, CA, USA). PCR was performed
using the primer assays for human vascular endothelial growth
factor (VEGF, NM_003376.4, catalog number PPH00251B) and
von Willebrandt factor (vWF, NM_000552.3, catalog number
PPH02567E), all purchased from Biomol (SuperArray, Frederick,
MD, USA). The expression of glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH, NM_002046.3, catalogue number
PPH00150E) was measured as reference gene.
A melting curve analysis was applied to ensure the specificity of
the PCR reaction. Relative quantification of the mRNA levels of
the target genes was determined using the comparative CT
(threshold cycle values) method (2
2DCT method). The results are
presented as fold change to GAPDH gene expression. This
experiment was performed with 4 independent EPC preparations.
Animals and Cell Transplantation
Eight-week old male Sprague-Dawley rats (n=12, Charles
River, Germany), weighing approximately 350–400 g were
housed, four animals per cage under standardized conditions:
15–21uC, air flow and light (12 h day/12 h night), rat food and
water ad libitum.
The rats were randomly allocated to the control (n=6) or
experimental group (n=6). Control animals were implanted with
BG40 biomaterial (disc shaped, 5 mm diameter, 1 mm thickness),
experimental animals received BG40 seeded with 5610
5 rat EPCs
1 h before implantation. General anesthesia was administered
intraperitoneally as a mixture of Ketavet and Rompun. All efforts
were made to minimize suffering. To create a critical size defect
(CSD) the head was shaved and cleaned with antiseptic fluid. A
lateral longitudinal incision over the head was made under aseptic
conditions. The skull cortex was drilled using a 6 mm bit so that a
circular critical calvarial bone defect of 6 mm was created. The
biomaterials were implanted into the defect zone and their
position controlled. The wound was then closed with continuous
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Animals had free access to food and water and were monitored
daily in the postoperative period for any complications or
abnormal behaviour.
The animals were sacrificed with an overdose of pentobarbital
(150 mg/kg i.p.) and weighed after 1 week. The skull bone was
dissected free and removed. Bones were wrapped in gauze
moistened with physiologic NaCl-solution and stored at 280uC
until preparation for immuno-histological examination.
von Willebrand Factor (vWF) as Marker of Early
Vascularization
Skull bones were fixed in 4% Zinc-Formal-Fixx, 4% (Thermo
Electron, Pittsburgh, USA) for 20 hrs, decalcified over 7 days in a
10% Tris buffered EDTA-solution under continuous stirring and
embedded in paraffin. Sections (5 mm) of the decalcified specimens
parallel to the long axis of the head were stained with hematoxylin
and eosin or incubated with a mouse anti vWF-antibody, which
crossreacts with both human and rat vWF (8 mg/mL, Biomol,
Hamburg; Germany). An isotype identical (IgG1) non specific
mouse antibody served as negative control (Dako, Hamburg,
Germany). As secondary antibody, a polymer HRP-conjugated
goat anti mouse antibody (Histofine simple stain rat Max Po (M),
Nichirei Biosciences, Tokyo, Japan) was applied and the sections
were incubated with 3-amino-9-ethylcarbazole (AEC, Lab Vision,
Dreieich, Germany). Finally, a counterstain with hematoxylin was
performed. One slide per animal was analyzed using light
microscopy (Axioobserver Z1, Zeiss, Gottingen, Germany) at a
magnification of 100x in combination with a computer-supported
imaging picture analysis system (Axiovision 4.7; Zeiss). Von
Willebrandt factor positive blood vessels with a lumen were
counted in 6 non overlapping images/slide/animal sourrounding
the defect area and the mean number of vessels was calculated.
These means were subsequently used for statistical anlysis. Cells
positive for von Willebrandt factor were not considered. Imaging
and blood vessel counting were performed with blinded specimens
examined in random order by an independent observer, blinded to
the group setup.
Statistics
Results are presented as box-plots of the median in figures, 25%
and 75% quartiles ((M (25%q/75%q)) in the text and tables.
Nonparametric Kruskal–Wallis test and multiple Conover-Iman
test were consequently used, and a Bonferroni-Holm corrected
p,0.05 was used to indicate statistical significance. Statistics were
calculated using the software Bias 10.03 (Epsilon-Verlag, Darm-
stadt, Germany).
Results
Biomaterial Characterization and Calcium Release
Scanning electron microscopy revealed a relatively smooth
surface of the composite biomaterial BG40. Higher magnification
revealed fibrous structure with a fiber diameter of approximately
0.1 mm. The fibres were partly arranged in parallel structures but
also significant areas of irregularly arranged fibres were found.
Putatively not interconnecting micropores with a diameter ranging
from 0.2 mm up to 1.2 mm were evenly distributed on the surface
at a median density of 58 micropores/1000 mm
2 (Figure 1B).
The release of ionic calcium by BG20 as well as BG40 was
significantly elevated in comparison to b-TCP during the whole 10
day observation period. The amount of released calcium ions
through BG40 was significantly higher, compared to BG20 (d6,
d10). The majority of calcium was released between days 1 and 2
(BG20 57% of total d10 release); BG40 74% of total d10 release,
Figure 1C).
Seeding Efficacy of Early EPCs on the Composite
Biomaterial
Seeding efficacies of EPCs were comparable between b-TCP
and BG40. The percentage of initially adhering EPCs was
significantly decreased on PLA, compared to b-TCP (Figure 2A).
Vitality and Function of EPCs Cultured on the Composite
Biomaterial
Scanning electron microscopy performed on the first day after
EPC seeding revealed evenly distributed EPCs on PLA and BG40.
EPCs demonstrated a rounded phenotype on BG40 and a more
flattened appearance when seeded on PLA (Fig. 2B). EPCs
cultured 5 days on PLA demonstrated a necrotic phenotype,
whereas EPCs cultured for the same time period on BG40 had a
vital appearance (Fig. 2B).
Additional fluorescence microscopy analysis was performed for
confirmation. Dil-ac-LDL prestained EPC were seeded onto the
biomaterials. The number of adhering EPC was significantly
decreased on PLA in comparison to BG20 and BG40 on day 3
after cell seeding but those differences were levelled on day 5,
though (Fig. 2C). Necrotic EPC were identified through an
additional DAPI-staining as indicated in the Materials and
Methods-section. The percentage of necrotic EPC was signifi-
cantly increased on PLA compared to EPCs that have been
cultured on BG20 and BG40 (Fig. 2C, 2D).
The gene expression of VEGF and vWF was evaluated to
determine the endothelial function of EPCs cultured on the
composite materials over a period of 5 days. Gene expression is
presented as fold change of the housekeeping gene expression
(GAPDH). VEGF gene expression remained stable on BG40 on
day 3 and day 5 in comparison to day 0, whereas VEGF gene
expression decreased singificantly from day 0 to day 5 on BG20
and PLA. No significant differences were found between the PLA,
BG20 and BG40 on day 3 and day 5 however a trend towards
higher values were seen for BG40 vs PLA on day 5 (p=0.1)
(Table 1). The gene expression of vWF increased significantly from
day 0 to day 5 for all biomaterials. No significant differences
between PLA, BG20 and BG40 were found albeit a trend for
increased vWF-gene expression on BG40 in comparison to PLA
on day 5 (p=0.1, Table 1).
Effect of Composite Scaffolds on EPC Morphology,
Function and Survival
The co-incubation of EPCs with BG40, and to a lesser extent
with BG20, resulted in significant EPC elongation compared to
control (medium), PLA and b-TCP. These changes became
prominent on day 6 and day 10 after incubation started (Figure 3A,
B).
To test the hypothesis that calcium released by the composite
biomaterials is critical, calcium was added to the medium in a final
concentration of 10 mM. This concentration was comparable to
the calcium released by BG40 in the experimental setting
(Figure 1C). The elongation of the cells was assessed five days
later. In line with the aforementioned results a statistically
significant increase in cell length was observed (Figure 4A, B).
As final proof that calcium derived from bioglass induces EPC
elongation, EPCs were incubated over a period of five days with
medium conditioned with BG40 (over 2 days) in the presence or
absence of the specific calcium chelator EGTA (ethylene glycol
tetraacetic acid). The addition of EGTA lowered the Ca
2+
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decline of EPC length in the presence of EGTA was apparent
(Figure 4A). A Dil-ac-LDL-staining performed in parallel proved
the vitality and endothelial function of the EPCs (Figure 4A, B, C).
The mean DiL-ac-LDL uptake per cell was comparable in all
groups (Control: 31 (25/44); 10 mM CaCl2:27 (22/43); BG40:36
(26/46); BG40+EGTA: 32 (27/44), not significant).
Next, the influence of Ca
2+ ions added to the medium on EPC
survival was investigated. In the control experiment the number of
EPC/field of view (FOV) declined significantly between day 1 and
day 5 (99 (78/130) vs 51 (46/57), p,0.05). In contrast, EPCs/
FOV remained stable between days 1 and 5 in the presence of
BG40 (Day 1:106 (93/120) vs day 5:93 (86/99), not significant) or
CaCl2 [10 mM, added to medium] (Day 1:104 (91/111) vs day
5:85 (75/105), not significant). Additionally, cell numbers in the
presence of BG40 or CaCl2 in the medium were significantly
elevated, compared to the control at day 5. To investigate whether
EPC maintenance was due to CaCl2 mediated apoptosis
inhibition, EPC apoptosis over a period of three days with and
without 10 mM CaCl2 was followed by apoptosis measurement. A
significantly decreased rate of apoptotic EPCs under the influence
of 10 mM CaCl2, compared to controls was observed (Control:
30.4% (28.1/33.2) vs CaCl2:8.6% (8.5/10.6); p,0.05). Represen-
tative dotblots of the measurement are depicted in figure 5.
Effect of BG40 and BG40+EPC on Early Vascularization in
vivo
Areas of neovascularization in the critical calvarial bone defect
of rats treated with BG40 or BG40+ EPC were detected after 1
week by vWF staining (Fig. 6A, 6B).
The histomorphometric analysis demonstrated significantly
higher blood vessel density surrounding the defect area in samples
obtained from animals receiving BG40 loaded with EPCs,
compared to samples from animals treated with BG 40 alone
(Fig. 6E, p,0.015). Besides the increased amount of vWF positive
structures, more large vessels in the newly formed tissue were
detectable (Fig. 6A, 6B) under the influence of BG40+ EPCs,
compared to BG40 alone.
Discussion
This study demonstrates that EPCs can successfully be cultured
on a PLA/bioglass composite biomaterial and that calcium
released from the bioglass fraction leads to significant elongation
and significantly improved survival of EPCs in vitro. In vivo, EPCs
seeded onto BG40 induce significantly improved early vascular-
ization to a critical size skull defect in the rat one week after
implantation.
Physical Properties
Ideal biomaterials for bone reconstruction should fulfill
requirements including mechanical stability, osteoinductivity,
osteoconductivity and support of revascularization. Currently
available single component materials do not meet all these
requirements. Hence, more sophisticated biomaterials are needed
and combining different biodegradable biomaterials with comple-
mentary properties may circumvent individual shortcomings.
In the present investigation a novel composite biomaterial based
on a PLA carrier and a bioglass fraction, consisting of calcium
oxide and silicium dioxide, was investigated. PLA is highly
biocompatible with better thermal processability than other
biopolymers. The main limitations of PLA are poor toughness,
slow degradation and hydrophobic properties resulting in low cell
affinity [37]. Pure bioglass is hard and brittle but offers a surface
Figure 2. Seeding efficacy and EPC phenotype on the composite scaffold. Seeding efficacy of EPCs on BG40, BG20, PLA and b-TCP (A). The
percentage of initially adhering EPCs on b-TCP was significantly increased compared to PLA. Appearance of EPCs seeded on BG40 on day 1 and day 5
(B). Representative SEM images are shown. EPCs demonstrated a spherical structure on the first day after seeding on BG40 whereas a flattened
appearance was seen when EPCs were seeded on PLA. On day 5 EPCs presented a necrotic phenotype when seeded on PLA, whereas they appear
vital on BG40. Scale bars indicate 60 mm (day 1: PLA, BG40) respectively 20 mm (day 5: PLA, BG40). *: p=0.045 b-TCP vs. PLA, n=5. Confirmation of
increased necrosis of EPC on PLA compared to BG20 and BG40, representative fluorescence microscopy images were shown in (C) at an original
magnification of 100 fold. DiL-ac-LDL prestained EPCs were seeded onto the scaffolds. DAPI was added over a period of 3 min to discriminate
between live (red cytoplasm, no blue nucleus) and necrotic EPCs (red cytoplasm, blue nucleus) on day 3 or 5 after seeding. The quantitative
evaluation of this experiment is depicted in (D). The number of EPC was significantly lowered on PLA on day 3 (p=0.02 vs BG20, p=0.01 vs BG40) and
the percentage of necrotic EPCs differed significantly between PLA and BG40 on day 3 (p=0.02) and day 5 (p=0.02). *: p,0.05 vs. PLA, $: p=0.045
BG40 vs. BG20; P: PLA; B2: BG20; B4: BG40, n=5. Scale bar indicates 200 mm.
doi:10.1371/journal.pone.0079058.g002
Table 1. Gene expression of VEGF and vWF in EPC cultured
on PLA, BG20 and BG40 over a period of 5 days.
Gene Biomaterial Day 0 Day 3 Day 5
VEGF PLA 0.0079 0.0026 0.0014
(0.0045/0.0107) (0.0016/0.0066) (0.0002/0.0027)
Q p=0.03 vs. day 0




BG40 0.0079 0.0425 0.0075
(0.0045/0.0107) (0.0004/0.35) (0.0025/0.014)
q p=0.1 vs PLA day
5
vWF PLA 0.0056 0.0136 0.0153
(0.0017/0.0072) (0.0102/0.0184) (0.0105/0.0211)
q p=0.04 vs day 0
BG20 0.0056 0.018 0.0141
(0.0017/0.0072) (0.0073/0.013) (0.0111/0.1902)
q p=0.05 vs day 0




q p=0.04 vs day 0
q p=0.1 vs PLA day
5
The values are given as fold change to the expression of the GAPDH gene
which served as housekeeping gene (median value (25% quartile/75% quartile).
Day 0 demonstrates the gene expression of the EPC before seeding on the
biomaterials. Generally, gene epression of VEGF declined over the time whereas
gene expression of vWF increased during the observation period. The
experiment was performed with 4 independent EPC preparations.
q=increased gene expression; Q=decreased gene expression.
doi:10.1371/journal.pone.0079058.t001
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influences the local environment by releasing bioactive ions such
as ionic calcium [38], which may lead to improved cellular
responses at the implantation site [39].
The composite BG40 demonstrated a relatively smooth surface
with fibrous structures in the submicrometer scale, and small pores
were present in high density. The occurrence, size and form of
distinct micro- and macroporous structures on PLA2/bioglass
based biomaterials depend on the fabrication process [37]. Apart
from structural aspects due to different fabrication processes,
composites containing a bioglass component share the common
feature of releasing ions such as calcium.
In line with previous reports a significant Ca
2+ release was
observed with the bioglass composites employed in this investiga-
tion. The vast majority of ionic calcium was set free within the first
two days, but further calcium release to the medium occurred over
the following eight days. Similar release dynamics have been
obtained using PLA with a bioglass fraction [34] and PGLA
composites supplemented with bioglass [40]. However, the
amount of calcium released has differed among studies, possibly
due to the different fractions of bioglass within the biomaterials
Figure 3. Coincubation of EPCs with BG40 and BG20 leads to EPC elongation. Incubation with BG20 (B2) and BG40 (B4) lead to a
significantly sustained increase in EPC length compared to EPCs incubated with b-TCP (T), PLA (P) or the medium control (C) during the whole
observation period (A). The length of EPCs incubated with BG20 and BG40 increased significantly from day 2 to day 10 (A). Representative
micrographs of EPCs incubated with either medium, PLA or BG40 demonstrated EPC elongation (B). *=p,0.05 BG20, BG40 vs control, b-TCP, PLA;
$=p,0.05 d6, d10 vs d2; #=b-TCP vs control, n=5.
doi:10.1371/journal.pone.0079058.g003
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release experiments.
It should be noted that the form of the biomaterials influences
the properties of the biomaterial [41]. In the current investigation
film like discs of the composite material were employed. Granules
of BG20 and BG40 might have accelerated calcium release due to
the higher surface area compared to disc shaped biomaterials. A
greater surface area might also allow higher loading with
regenerative cells.
Bioglass Effect on Cells and Vascularization in vitro and in
vivo
The initial adhesion of EPCs on the bioglass composites BG20/
BG40 and on b-TCP was comparable but significantly lower,
compared to former studies [30–32]. These deviating results might
be explained by alterations in the seeding procedure, which was
performed in 96 well plates with comparatively low cell numbers
in the present investigation. In former studies an EPC seeding
efficacy of over 90% on b-TCP has been demonstrated [19].
Seeding efficacy on BG20/BG40 may be equally good if the same
seeding conditions are applied.
The in vitro investigation demonstrated that BG40 induced the
best EPC differentiation and survival, which hypothetically could
result in better vascularization of a bone critical size defect in vivo.
To test this, the composite biomaterial BG40 with or without
EPCs, was implanted into a critical size calvarial defect and early
vascularization was analyzed. Much better vascularization was
observed in animals receiving BG40 and EPCs. The experimental
setup did not provide an evaluation of the effect of BG40 alone on
early vascularization since BG40 without EPCs was not tested.
Two factors possibly play a dominant role in the increased
in vivo vascularization. First, it has been demonstrated in different
animal models that early EPCs increase vascularization
[32,33,42]. Second, the beneficial effects of calcium ions released
by the bioglass component might also contribute to the increased
vascularization in vivo by supporting EPC function and survival.
Separating the effects of the bioglass from the effects of EPCs on
vascularization in this in vivo model will require future investiga-
tion.
The contribution of early EPCs in forming blood vessels is a
matter of debate. Crosby and colleagues have reported that 8.3%
–11.2% of endothelial cells that developed in sponge induced
granulation tissue over 1 month were derived from circulating
hematopoietic progenitor cells [43]. Hence, it is has been proposed
that early EPCs more likely act in a paracrine manner, secreting
proangiogenic factors such as VEGF [22]. Previous findings,
whereby human early EPCs were implanted in a rat critical size
defect of the femur, support this hypothesis. When the animals
Figure 4. Calcium released by BG40 induces EPC elongation. EPCs were incubated in the presence of either 30 mg BG40/mL, 10 mM Ca
2+ or
BG40 conditioned medium+EGTA [3 mM]. Cell length was determined on day five (A) by means of phase contrast microscopy and subsequent
histomorphometric evaluation. In (B) corresponding micrographs of EPCs are shown. The elongation of the EPCs was significantly lower in the
presence of the calcium chelator EGTA [3 mM]. The uptake of DiL-ac-LDL demonstrated the endothelial phenotype and EPC vitality. The mean DiL-ac-
LDL amount per cells was not significantly altered among the groups (control, 10 mM calcium, BG40, BG40+EGTA) (C). *=p,0.05 vs control;
$=p,0.05 vs BG40+EGTA, n=5. Scale bars indicate 200 mm.
doi:10.1371/journal.pone.0079058.g004
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2+ [10 mM]. Apoptosis was measured by Annexin-staining, necrotic cells
were stained with 7-AAD. Representative dot blots of the FACS-analysis are presented. Cells with appropriate forward/sideward scatter characteristics
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expression and distribution of the human cells were analyzed a
significantly elevated expression of VEGF in the defect area,
compared to control animals without EPC, was observed. In
contrast, the incorporation of the human cells in vWF-positive
vessel structures was a rare event [33].
A stimulating effect of ionic products released by bioglass on
osteogenic cell types has been reported in several investigations.
Kaufmann et al. have reported an up-regulation of osteogenic
were gated (‘‘R1’’, A). The percentage of apoptotic cells was subsequently determined through quadrant analysis. Early and late apoptotic EPCs were
located in quadrants Q3 and Q4, respectively. The percentage of apoptotic cells consists of the sum of early and late apoptotic cells. Apotosis of early
EPCs in the control experiment is shown in (B) and in the presence of Ca
2+ in (C).
doi:10.1371/journal.pone.0079058.g005
Figure 6. BG40+EPC increase vascularization one week after implantation. Representative vWF-stained histological sections of the defect
site of male rats treated with BG40 (A, n=6) and BG40+EPC (B, n=6). The blood vessel density increased significantly in animals treated with
BG40+EPC, compared to BG40 alone (B). vWF-positive structures appear brown (arrows). The isotype control is presented in figure 6C. The absence of
staining in blood vessel structure (arrows) indicates the specificity of the vWF-staining (C). An overview of the defect area is provided in d (original
magnification 50x). The BG40 implant could not be preserved during sample sectioning and left a gap corresponding to the BG area (defect site). The
skull bone is located in the right corner (skull). The encircled area marks the region shown at higher magnification (original magnification 200x) in (A)
and (B). The quantitative evaluation of vWF-positive blood vessel structures is depicted in (e). All vWF-positive, blood vessel like structures in the
neighborhood of the whole defect site were counted. Red scale bars: 100 mm (A, B, C), 500 mm (D), *: p=0.015.
doi:10.1371/journal.pone.0079058.g006
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osteoblasts cultured with bioglass [44]. Jell and coworkers have
reported a significant up-regulation of osteogenic markers such as
alkaline phosphatase and bone sialoprotein in osteoblasts incubat-
ed with bioglass conditioned medium [45].
More recently, different aspects of the proangiogenic potential
of biomaterials containing bioglass have also been described. Day
and colleagues have demonstrated enhanced synthesis of VEGF
and basic fibroblast growth factor after incubating fibroblasts with
bioglass [46]. Leu and Leach have shown that low concentrations
of bioglass possess proangiogenic potential when they incubated
human microvascular endothelial cells with bioglass conditioned
medium. A dose dependent significant increase in cell prolifera-
tion, tube formation and VEGF-synthesis in vitro was observed
[47]. The same group analyzed the angiogenic response to
bioactive glass in an irradiated calvarial defect in rats. A bilateral
calvarian defect was created and filled with a bioglass supple-
mented collagen sponge. An empty collagen sponge served as
control. Significantly greater neovascularization within the defect
in the presence of bioglass indicates a proangiogenic effect of this
material [48].
The effect of a composite biomaterial consisting of a PLA-
component and bioglass on EPC has recently been investigated by
Aguirre et al. [34]. They report a significant increase of VEGF
production and tube density if EPCs were seeded on a PLA-
bioglass composite. However, the type of EPCs that were used in
that study is not clearly defined. Based on the protocol for isolation
and differentiation of the EPC it may be assumed that ‘‘late’’ EPCs
(CD133 positive cells) were employed.
In the present study early EPCs were used [19,30–33]. In
accordance to Aguirre et al. [34] an elongation of EPCs, which
indicates sprouting activity [21,28,35], was observed after incuba-
tion with bioglass, correlating to the calcium concentration
available in the medium.
A trend toward increased gene expression of VEGF and vWF
was seen after incubation of EPC on BG40 in comparison to EPC
cultured on PLA. This result is not as distinct as described by
Aguirre et al who observed a significant up regulation of VEGF in
EPC after incubation on a PLA-bioglass composite material [34].
This inconsistency might be due to differences in the mixture of
the composite biomaterials, the sort of EPC and different
measurement points (day 1 [34] vs. day 3, day 5 in this work).
Calcium ions released by the bioglass might enhance the
expression of both genes as it was discussed for VEGF by Aguirre
et al [34]. The general increase of vWF gene expression of early
EPC cultured on PLA and PLA-bioglass composite materials has
not been described yet and might indicate a generally advanced
endothelial differentiation of the EPC over the time [21].
The phenotypic changes of the early EPC were associated with
a decline in EPC apoptosis in our experiments. Calcium mediates
diverse cell processes and improved EPC survival may be due to a
calcium dependent activation of PI3K, which activates the protein
kinase Akt, a multifunctional regulator of EPC survival [28]. Cell
shape alteration might occur over calcium mediated activation of
rho-kinase (ROCK), a key regulator of cytoskeleton and cell
polarity [49].
Conclusion
The present study demonstrates that the composite materials
BG20 and BG40 support the function and survival of EPCs in vitro
and that those effects are mediated by calcium released from the
biomaterials. These observations suggest that improved EPC
sprouting and delayed apoptosis should not only be seen as a pure
in vitro phenomenon but may also be relevant to the improved
vascularization in the skull defect model in vivo. It has become
evident that understanding the effects of calcium ions on EPCs
in vitro and in vivo requires further investigation. Elucidating
underlying molecular mechanisms and subsequent optimization
of the ionic components of bioglass may help to develop more
effective biomaterials.
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